Key result
Highest antioxidant diet score linked to ~17% lower all-cause mortality in CKD patients.
Why the study?
The relationship between dietary antioxidant intake and mortality in patients with CKD, particularly cause-specific mortality, was unclear.
Does a higher Composite Dietary Antioxidant Index (CDAI) reduce mortality in adults with chronic kidney disease?
Cohort (n=6,379)
Yes
Does a higher Composite Dietary Antioxidant Index (CDAI) reduce mortality in adults with chronic kidney disease?
Answers are grounded in this paper and cite their sources.
A higher Composite Dietary Antioxidant Index is associated with reduced all-cause and cancer mortality, but not cardiovascular mortality, in adults with chronic kidney disease.
At present, the relationship between the intake of antioxidants in food and the mortality rate of patients with chronic kidney disease (CKD), especially the association with the mortality rate of specific causes, is not clear. This study included 6379 adult CKD patients from the National Health and Nutrition Examination Survey (2001-2018). Use the Cox proportional hazards model, restricted cubic spline (RCS) model, and stratified and sensitivity analysis to evaluate the relationship between the Composite Dietary Antioxidant Index (CDAI) and mortality in patients with chronic kidney disease. During the follow-up period, 2381 all-cause deaths were recorded, including 719 deaths from cardiovascular disease, 132 deaths from cerebrovascular disease, and 430 deaths from cancer. We found that compared to the lowest quartile of CDAI, the weighted multivariate hazard ratio of participants in the highest quartile was 0.83 (95% confidence interval: 0.72, 0.96) for all-cause mortality, Cardiovascular mortality was 0.91 (95% confidence interval: 0.70, 1.18), Cerebrovascular death was 0.51 (95% confidence interval: 0.24, 1.07), Death due to cancer was 0.64 (95% confidence interval: 0.45, 0.92). RCS analysis shows a non-linear relationship between CDAI and all-cause mortality and cancer mortality. At the same time, there is no non-linear relationship between CDAI and cardiovascular mortality and cerebrovascular mortality. Stratified analysis shows that race and BMI are influencing factors for CDAI-CKD mortality. Sensitivity analysis confirmed the robustness of the results. Our research findings emphasize the potential advantages of an antioxidant diet in reducing the risk of mortality in CKD patients.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) conducted a cohort in Chronic kidney disease (n=6,379). Composite Dietary Antioxidant Index (CDAI) vs. Lowest quartile of CDAI was evaluated on All-cause mortality (HR 0.83, 95% CI 0.72-0.96). The highest quartile of the Composite Dietary Antioxidant Index was associated with a reduced risk of all-cause mortality (HR 0.83; 95% CI 0.72-0.96) compared to the lowest quartile in CKD patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: